Vertex stock falls after FDA halts diabetes study in surprise move - The Boston Globe
Diabetes Tips, News & Articles
Vertex Pharmaceuticals shares tumbled after US regulators placed its study of a key new treatment for type 1 diabetes on clinical hold.
Note: This news content is auto-generated from a syndicated feed.
If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online
Vertex Pharmaceuticals shares tumbled after US regulators placed its study of a key new treatment for type 1 diabetes on clinical hold.
Vertex Pharmaceuticals shares tumbled after US regulators placed its study of a key new treatment for type 1 diabetes on clinical hold.
Read moreNote: This news content is auto-generated from a syndicated feed.
If you have a family history of diabetes you could be at risk, get tested now! Book Diabetes test online